Impact of blood glucose control on sympathetic and vagus nerve functional status in patients with type 2 diabetes mellitus

被引:21
|
作者
Yu, Yijun [1 ,2 ]
Hu, Liqun [1 ,2 ]
Xu, Yanling [1 ,2 ]
Wu, Shiwei [1 ,2 ]
Chen, Yafei [1 ,2 ]
Zou, Wusong [1 ,2 ]
Zhang, Mingjing [1 ,2 ]
Wang, Yuting [1 ,2 ]
Gu, Ye [1 ,2 ]
机构
[1] Huazhong Univ Sci & Technol, Dept Cardiol, Wuhan Hosp 4, HanZheng St 473, Wuhan 430033, Peoples R China
[2] Huazhong Univ Sci & Technol, Puai Hosp, Tongji Med Coll, HanZheng St 473, Wuhan 430033, Peoples R China
关键词
Type 2 diabetes mellitus; Glycosylated hemoglobin; Sympathetic nerve; Vagus nerve; Heart rate recovery; Heart rate variability; HEART-RATE-VARIABILITY; CARDIOVASCULAR AUTONOMIC NEUROPATHY; GLYCEMIC CONTROL; RATE RESPONSE; RATE RECOVERY; RATE PROFILE; EXERCISE; ASSOCIATION; FAILURE; HBA1C;
D O I
10.1007/s00592-019-01393-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims Present study observed the impact of blood glucose control on sympathetic and vagus functional status in type 2 diabetes mellitus (DM) patients through observing the association between glycosylated hemoglobin (HbA1c) level and sympathetic and vagus functional status detected by heart rate recovery (HRR) and heart rate variability (HRV) assessments. Methods Consecutive hospitalized DM patients were divided into well glycemic control group (HbA1c < 7.0%, group WGC, n = 100) and poor glycemic control group (HbA1c >= 7.0%, group PGC, n = 100), 100 hospitalized patients without DM served as control group (group C). All subjects underwent blood biochemistry test, treadmill exercise testing and 24-h Holter monitoring. Results HRR and HRV parameters were significantly lower in group WGC and PGC than in group C. Standard deviation of NN intervals (SDNN), standard deviation of all 5-min average NN intervals (SDANN), very low frequency (VLF) values were significantly lower in group PGC than in group WGC. HbA1c level was negatively correlated with HRR1, SDNN, SDANN, VLF, low frequency and high frequency. Logistic regression analysis showed that lower SDNN, SDANN and VLF values were risk factors for high HbA1c levels in DM patients after adjusting for gender, age and beta-blocker use in the model 1, and for gender, age, beta-blocker use, coronary artery disease and hypertension in the model 2. Conclusions Present results indicate that sympathetic and vagal functional status are impaired independent of HbA1c level, while poor glycemic control is related to more significant neurocardiac dysfunction in DM patients.
引用
收藏
页码:141 / 150
页数:10
相关论文
共 50 条
  • [41] Influence of Vitamin- D- Supplementation on Blood Glucose Control in Patients with Diabetes mellitus Type 2
    Spranger, S.
    DIABETOLOGE, 2015, 11 (07): : 587 - 588
  • [42] Poor Control of Blood Glucose, Lifestyle, and Cardiometabolic Parameters in Younger Adult Patients with Type 2 Diabetes Mellitus
    Nam, Ga Eun
    Han, Byoungduck
    Joo, Chae Lin
    Kang, Seo Young
    Lim, Jisun
    Kim, Yang-Hyun
    Park, Hye Soon
    JOURNAL OF CLINICAL MEDICINE, 2019, 8 (09)
  • [43] Association between self-monitoring of blood glucose and glycemic control in patients with type 2 diabetes mellitus
    Wen, L
    Parchman, ML
    Linn, WD
    Lee, S
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2004, 61 (22) : 2401 - 2405
  • [44] STUDY ON EFFECT OF STANDARDIZED INSULIN INJECTION TECHNIQUE ON MENTAL STATUS AND BLOOD GLUCOSE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
    Wang, Yanyan
    Wei, Qirong
    Xu, Xinyan
    ACTA MEDICA MEDITERRANEA, 2021, 37 (04): : 2433 - 2438
  • [45] Family Support and Blood Glucose Control in Patients With Diabetes Type 2
    Jimenez Arias, Priscila Mireya
    Cisneros Jimenez, Maria de Jesus
    Guzman Pantoja, Jaime Eduardo
    Robles Romero, Miguel Angel
    ATENCION PRIMARIA, 2008, 40 (09): : 477 - 477
  • [46] Repaglinide improves blood glucose control in patients with type 2 diabetes
    不详
    FORMULARY, 2004, 39 (11) : 528 - 528
  • [47] HEALTH STATUS AND GLYCAEMIC CONTROL IN GERIATRIC PATIENTS WITH TYPE 2 DIABETES MELLITUS
    Libiseller, A.
    Lichtenegger, K.
    de Campo, A.
    Wiesinger, T.
    Stolletz, N.
    Cuder, G.
    Beck, P.
    Plank, J.
    Hoell, B.
    Pieber, T.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2018, 20 : A65 - A65
  • [48] Screening for Abnormal Blood Glucose and Type 2 Diabetes Mellitus
    Barkoudah, Ebrahim
    Weinrauch, Larry A.
    ANNALS OF INTERNAL MEDICINE, 2016, 165 (03) : 225 - 225
  • [49] Bezafibrate reduces blood glucose in type 2 diabetes mellitus
    Ogawa, S
    Takeuchi, K
    Sugimura, K
    Fukuda, M
    Lee, R
    Ito, S
    Sato, T
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2000, 49 (03): : 331 - 334
  • [50] Screening for Abnormal Blood Glucose and Type 2 Diabetes Mellitus
    Ngo-Metzger, Quyen
    Owings, John
    AMERICAN FAMILY PHYSICIAN, 2016, 93 (12) : 1025 - 1026